Amgen is taking a closer look at using T cells for inflammation, announcing a new deal Tuesday with TCR upstart TScan Therapeutics. The companies will team up to discover new targets for Crohn’s disease, and Amgen has the option to expand the agreement into ulcerative colitis. Amgen is paying $30…
...
News Ticker
- [ June 5, 2023 ] Amgen continues to target mid-December deadline for Horizon deal close Los Angeles Biotech News
- [ June 5, 2023 ] Akero’s NASH candidate reduces liver fat in patients taking a GLP-1 Los Angeles Biotech News
- [ June 5, 2023 ] Pharmaceutical Visual Inspector Technician – MedisourceRx – Los Alamitos, CA Los Angeles Biotech Jobs
- [ June 5, 2023 ] Atara Biotherapeutics Presents Updated Tab-cel® Clinical Effectiveness Data at ASCO 2023 Los Angeles Biotech News
- [ June 5, 2023 ] Bansk Group-Backed Arcadia Consumer Health Acquires Avrio Health Los Angeles Biotech News
Copyright © 2021 Biotech Networks, LLC
